BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31858727)

  • 1. "Splitting the matrix": intussusceptive angiogenesis meets MT1-MMP.
    D'Amico G; Muñoz-Félix JM; Pedrosa AR; Hodivala-Dilke KM
    EMBO Mol Med; 2020 Feb; 12(2):e11663. PubMed ID: 31858727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial MT1-MMP targeting limits intussusceptive angiogenesis and colitis via TSP1/nitric oxide axis.
    Esteban S; Clemente C; Koziol A; Gonzalo P; Rius C; Martínez F; Linares PM; Chaparro M; Urzainqui A; Andrés V; Seiki M; Gisbert JP; Arroyo AG
    EMBO Mol Med; 2020 Feb; 12(2):e10862. PubMed ID: 31793743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/ccl2 and interleukin-8/CXCL8 in endothelial cells during angiogenesis.
    Gálvez BG; Genís L; Matías-Román S; Oblander SA; Tryggvason K; Apte SS; Arroyo AG
    J Biol Chem; 2005 Jan; 280(2):1292-8. PubMed ID: 15516694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI; Soroceanu L; Strongin AY
    Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression.
    Sounni NE; Devy L; Hajitou A; Frankenne F; Munaut C; Gilles C; Deroanne C; Thompson EW; Foidart JM; Noel A
    FASEB J; 2002 Apr; 16(6):555-64. PubMed ID: 11919158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prinomastat, a hydroxamate inhibitor of matrix metalloproteinases, has a complex effect on migration of breast carcinoma cells.
    Deryugina EI; Ratnikov BI; Strongin AY
    Int J Cancer; 2003 May; 104(5):533-41. PubMed ID: 12594807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase.
    Deryugina EI; Bourdon MA; Jungwirth K; Smith JW; Strongin AY
    Int J Cancer; 2000 Apr; 86(1):15-23. PubMed ID: 10728589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical.
    Nisato RE; Hosseini G; Sirrenberg C; Butler GS; Crabbe T; Docherty AJ; Wiesner M; Murphy G; Overall CM; Goodman SL; Pepper MS
    Cancer Res; 2005 Oct; 65(20):9377-87. PubMed ID: 16230401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase.
    Ratnikov BI; Rozanov DV; Postnova TI; Baciu PG; Zhang H; DiScipio RG; Chestukhina GG; Smith JW; Deryugina EI; Strongin AY
    J Biol Chem; 2002 Mar; 277(9):7377-85. PubMed ID: 11741954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
    Dahi S; Lee JG; Lovett DH; Sarkar R
    J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
    Hofmann UB; Westphal JR; Van Kraats AA; Ruiter DJ; Van Muijen GN
    Int J Cancer; 2000 Jul; 87(1):12-9. PubMed ID: 10861447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prointegrin maturation follows rapid trafficking and processing of MT1-MMP in Furin-Negative Colon Carcinoma LoVo Cells.
    Deryugina EI; Ratnikov BI; Yu Q; Baciu PC; Rozanov DV; Strongin AY
    Traffic; 2004 Aug; 5(8):627-41. PubMed ID: 15260832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells.
    Gálvez BG; Matías-Román S; Yáñez-Mó M; Vicente-Manzanares M; Sánchez-Madrid F; Arroyo AG
    Mol Biol Cell; 2004 Feb; 15(2):678-87. PubMed ID: 14657245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.
    Collen A; Hanemaaijer R; Lupu F; Quax PH; van Lent N; Grimbergen J; Peters E; Koolwijk P; van Hinsbergh VW
    Blood; 2003 Mar; 101(5):1810-7. PubMed ID: 12393408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix.
    Chun TH; Sabeh F; Ota I; Murphy H; McDonagh KT; Holmbeck K; Birkedal-Hansen H; Allen ED; Weiss SJ
    J Cell Biol; 2004 Nov; 167(4):757-67. PubMed ID: 15545316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease.
    Arroyo AG; Genís L; Gonzalo P; Matías-Román S; Pollán A; Gálvez BG
    Curr Pharm Des; 2007; 13(17):1787-802. PubMed ID: 17584108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins.
    Alonso-Escolano D; Strongin AY; Chung AW; Deryugina EI; Radomski MW
    Br J Pharmacol; 2004 Jan; 141(2):241-52. PubMed ID: 14691052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Membrane-Type 1 Matrix Metalloproteinase-Substrate Interactions in Pathogenesis.
    Lee H; Ibrahimi L; Azar DT; Han KY
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.